Filing Details

Accession Number:
0000899243-17-020638
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-17 19:45:41
Reporting Period:
2017-08-15
Filing Date:
2017-08-17
Accepted Time:
2017-08-17 19:45:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1014739 Bioscrip Inc. BIOS Services-Home Health Care Services (8082) 050489664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1356974 Coliseum Capital Partners, L.p. 105 Rowayton Avenue
Rowayton CT 06853
Yes No Yes No
1409585 Coliseum Capital, Llc 105 Rowayton Avenue
Rowayton CT 06853
Yes No Yes No
1409751 Coliseum Capital Management, Llc 105 Rowayton Avenue
Rowayton CT 06853
Yes No Yes No
1430708 S Christopher Shackelton 105 Rowayton Avenue
Rowayton CT 06853
Yes No Yes No
1454123 Adam Gray 105 Rowayton Avenue
Rowayton CT 06853
Yes No Yes No
1567187 Coliseum Capital Partners Ii, L.p. 105 Rowayton Avenue
Rowayton CT 06853
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-15 216,300 $3.15 5,406,110 No 4 S Indirect See Footnotes
Common Stock Disposition 2017-08-16 115,702 $3.11 5,290,408 No 4 S Indirect See Footnotes
Common Stock Disposition 2017-08-17 554,476 $3.05 4,735,932 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The Common Stock is held directly by (a) Coliseum Capital Partners, L.P. ("CCP") of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, (b) Coliseum Capital Partners II, L.P. ("CCP2" and, together with CCP, the "Funds"), an investment limited partnership of which CC is general partner and for which CCM serves as investment adviser, and (c) a separate account investment advisory client of CCM (the "Separate Account").
  3. Christopher Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC, and may be deemed to have an indirect pecuniary interest in the shares held by the Funds and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from the Funds. Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from from $3.00 to $3.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. Following the transactions reported herein, CCP, CCP2 and the Separate Account directly owned 2,945,866, 682,160 and 1,107,906 shares of Common Stock, respectively.